Pfizer enters into generic drug pact
January 6, 2010
According to the Associated Press, Pfizer will sell 40 generic drugs manufactured by an Indian company. The financial terms of the deal between Pfizer and Strides Arcolab were not disclosed, but the companies said Pfizer will sell injectable and oral drugs, many of which are treatments for cancer. The drugs are made by Strides Arcolab and two joint ventures between that company and Aspen Pharma of South Africa. Strides Arcolab is based in Bangalore, India. Pfizer will sell the products through its established products business unit.